159 related articles for article (PubMed ID: 19188483)
1. Colchicine: a novel positive allosteric modulator of the human 5-hydroxytryptamine3A receptor.
de Oliveira-Pierce AN; Zhang R; Machu TK
J Pharmacol Exp Ther; 2009 May; 329(2):838-47. PubMed ID: 19188483
[TBL] [Abstract][Full Text] [Related]
2. The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.
Yang KH; Galadari S; Isaev D; Petroianu G; Shippenberg TS; Oz M
J Pharmacol Exp Ther; 2010 May; 333(2):547-54. PubMed ID: 20160007
[TBL] [Abstract][Full Text] [Related]
3. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
[TBL] [Abstract][Full Text] [Related]
4. The effect of Δ9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density.
Yang KH; Isaev D; Morales M; Petroianu G; Galadari S; Oz M
Neuroscience; 2010 Nov; 171(1):40-9. PubMed ID: 20800662
[TBL] [Abstract][Full Text] [Related]
5. Mutations of L293 in transmembrane two of the mouse 5-hydroxytryptamine3A receptor alter gating and alcohol modulatory actions.
Hu XQ; Hayrapetyan V; Gadhiya JJ; Rhubottom HE; Lovinger DM; Machu TK
Br J Pharmacol; 2006 May; 148(1):88-101. PubMed ID: 16520747
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
7. Subunit-dependent modulation of the 5-hydroxytryptamine type 3 receptor open-close equilibrium by n-alcohols.
Rüsch D; Musset B; Wulf H; Schuster A; Raines DE
J Pharmacol Exp Ther; 2007 Jun; 321(3):1069-74. PubMed ID: 17360702
[TBL] [Abstract][Full Text] [Related]
8. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
9. Bicuculline antagonizes 5-HT(3A) and alpha2 glycine receptors expressed in Xenopus oocytes.
Sun H; Machu TK
Eur J Pharmacol; 2000 Mar; 391(3):243-9. PubMed ID: 10729364
[TBL] [Abstract][Full Text] [Related]
10. A role for the Val291 residue within the transmembrane domain 2 in diltiazem- and TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester]-mediated 5-hydroxytryptamine type 3A receptor regulations.
Lee BH; Choi SH; Pyo MK; Shin TJ; Hwang SH; Kim BR; Lee JH; Rhim H; Kim HC; Nah SY
Biol Pharm Bull; 2009 May; 32(5):861-7. PubMed ID: 19420755
[TBL] [Abstract][Full Text] [Related]
11. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
Solt K; Stevens RJ; Davies PA; Raines DE
J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
[TBL] [Abstract][Full Text] [Related]
12. Direct noncompetitive inhibition of 5-HT(3) receptor-mediated responses by forskolin and steroids.
Oz M; Zhang L; Spivak CE
Arch Biochem Biophys; 2002 Aug; 404(2):293-301. PubMed ID: 12147268
[TBL] [Abstract][Full Text] [Related]
13. Menthol inhibits 5-HT3 receptor-mediated currents.
Ashoor A; Nordman JC; Veltri D; Yang KH; Shuba Y; Al Kury L; Sadek B; Howarth FC; Shehu A; Kabbani N; Oz M
J Pharmacol Exp Ther; 2013 Nov; 347(2):398-409. PubMed ID: 23965380
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of a rat 5-hydroxytryptamine type3 receptor subunit (r5-HT3A(b)) expressed in Xenopus laevis oocytes.
Mair ID; Lambert JJ; Yang J; Dempster J; Peters JA
Br J Pharmacol; 1998 Aug; 124(8):1667-74. PubMed ID: 9756382
[TBL] [Abstract][Full Text] [Related]
15. Effects of triterpenoids from Poria cocos Wolf on the serotonin type 3A receptor-mediated ion current in Xenopus oocytes.
Lee JH; Lee YJ; Shin JK; Nam JW; Nah SY; Kim SH; Jeong JH; Kim Y; Shin M; Hong M; Seo EK; Bae H
Eur J Pharmacol; 2009 Aug; 615(1-3):27-32. PubMed ID: 19446542
[TBL] [Abstract][Full Text] [Related]
16. Effects of ginsenoside Rg2 on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.
Choi S; Lee JH; Oh S; Rhim H; Lee SM; Nah SY
Mol Cells; 2003 Feb; 15(1):108-13. PubMed ID: 12661769
[TBL] [Abstract][Full Text] [Related]
17. Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.
Gasiorek A; Trattnig SM; Ahring PK; Kristiansen U; Frølund B; Frederiksen K; Jensen AA
Biochem Pharmacol; 2016 Jun; 110-111():92-108. PubMed ID: 27086281
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol enhances 5-hydroxytryptamine type 3A receptor-mediated ion currents: the role of arginine 222 residue in pre-transmembrane domain I.
Lee BH; Hwang SH; Choi SH; Shin TJ; Kang J; Lee SM; Nah SY
Biol Pharm Bull; 2011; 34(4):523-7. PubMed ID: 21467640
[TBL] [Abstract][Full Text] [Related]
19. Competitive antagonism of the mouse 5-hydroxytryptamine3 receptor by bisindolylmaleimide I, a "selective" protein kinase C inhibitor.
Coultrap SJ; Sun H; Tenner TE; Machu TK
J Pharmacol Exp Ther; 1999 Jul; 290(1):76-82. PubMed ID: 10381762
[TBL] [Abstract][Full Text] [Related]
20. Nondepolarizing neuromuscular blockers inhibit the serotonin-type 3A receptor expressed in Xenopus oocytes.
Min KT; Wu CL; Yang J
Anesth Analg; 2000 Feb; 90(2):476-81. PubMed ID: 10648343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
